Needle-free Injection System - Stratis(R) - was used to deliver Scancell's iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 trial. -- The Scancell ...

Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...

Explore the potential of polysaccharide microneedles in cancer immunotherapy for effective drug delivery and immune ...

Please provide your email address to receive an email when new articles are posted on . Most participants who discontinued immunotherapy for 1 year after progression-free disease maintained control ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...

Patients discontinuing adjuvant immunotherapy early due to toxicity do not have inferior outcomes compared to those completing 12 months of treatment. The study found a 2-year recurrence-free survival ...

"3T is tackling one of the toughest challenges in immuno-oncology: delivering potent, selective TCR therapies for solid tumors," said Dr. Knudsen. "The science is compelling, and the opportunity for ...

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...

Bacteria in head and neck tumor stimulate immunotherapy resistance by attracting immune cells and creating a shield.